Highlights

• Sun Pharma Advanced Research Co. Ltd. surged around 17.48% in the latest session, indicating a strong rebound from recent lows.
• The stock has moved back above its 50-day Simple Moving Average near ₹127.95, suggesting improving short-term strength.
• Momentum indicators show recovery, with RSI near 58.49 indicating strengthening trend conditions.

Shares of Sun Pharma Advanced Research (NSE:SPARC)  rose nearly 17.48% to trade near ₹131.45 as of March 25, 2026, marking a sharp rebound after recent weakness. The stock has now moved above its 50-day Simple Moving Average of ₹127.95, suggesting early signs of trend stabilisation and improving short-term sentiment.

Despite the strong rally, the broader price structure still reflects a corrective phase. However, the recent upward move indicates a shift in momentum as buyers regain control at lower levels.

Financial Performance Overview

A detailed breakdown of the latest quarterly financial results has not been included in the provided data. However, the recent price action suggests that market participants are focusing more on short-term technical recovery rather than fundamental triggers.

Further clarity on revenue growth, profitability, and margin trends would be required to assess whether the rally is fundamentally driven or primarily technical in nature.

Trading Activity Reflects Strong Buying Interest

The sharp 17.48% rise highlights renewed buying interest after a period of correction. The move suggests short-covering and value buying at lower levels, indicating improving sentiment in the short term.

The breakout above the 50-day moving average is a key technical development, often seen as an early signal of trend recovery if sustained.

Technical Setup Shows Momentum Recovery

Sun Pharma Advanced Research Co. Ltd. is currently trading near ₹131.45 as of March 25, 2026, rising around 17.48%, indicating a strong upward move from recent lows. The price has moved back above its 50-day Simple Moving Average near ₹127.95, suggesting short-term strength after a corrective phase. The earlier structure showed a series of lower highs and lower lows, but the recent surge points to a rebound with improving price action.

The 14-day RSI near 58.49 reflects strengthening momentum. In the near term, support is placed around ₹120.00–₹110.00, while resistance is seen near ₹140.00–₹150.00.

Source: TradingView

Outlook Hinges on Sustained Breakout

In the near term, the stock’s direction will depend on whether it can sustain above its 50-day moving average and hold gains above ₹130 levels. A sustained breakout above resistance could confirm a stronger trend reversal.

However, failure to maintain momentum may result in another consolidation phase within the broader corrective structure.

Risk Factors to Watch

• Broader trend still reflects prior corrective structure.
  
  
• Sustaining above the 50-day moving average is crucial for continuation.
  
  
• Resistance near ₹140–₹150 may limit near-term upside.

FAQs

Why did Sun Pharma Advanced Research shares rise today?

The stock gained around 17.48% due to strong buying interest and a breakout above its 50-day moving average.

What is the key resistance level?

Immediate resistance is placed in the ₹140–₹150 range.

Is the trend fully reversed?

Not yet. While momentum has improved, the broader structure still reflects a prior corrective phase.